V-Co Investors 3 LLC - 31 Mar 2026 Form 3 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Reporting relationship
10%+ Owner
Issuer ticker
VVOS
Reported as of
31 Mar 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
10 Apr 2026, 16:54:28 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael C. Skaff, as Managing Director SP Manager LLC, Manager of V-Co Investors 3 LLC

Key filing fact

V-Co Investors 3 LLC filed Form 3 for Vivos Therapeutics, Inc. (VVOS) on 10 Apr 2026.

Key facts

  • This page summarizes V-Co Investors 3 LLC's Form 3 filing for Vivos Therapeutics, Inc. (VVOS).
  • 0 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 10 Apr 2026, 16:54.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002114460 Primary reporting owner

V-Co Investors 3 LLC

Relationship
10%+ Owner
Address
18000 MACK AVE, GROSSE POINTE
Signature
/s/ Michael C. Skaff, as Managing Director SP Manager LLC, Manager of V-Co Investors 3 LLC
Signature date
10 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VVOS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,353,625
Date
31 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VVOS holding Derivative

Pre-Funded Warrant

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
31 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
429,957
Exercise price
$0.000100
Footnotes
F1
VVOS holding Derivative

Series A Common Stock Warrant

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
31 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,783,582
Exercise price
$1.09
VVOS holding Derivative

Series B Common Stock Warrant

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
31 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,783,582
Exercise price
$1.09
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Pre-Funded Warrant has a term ending on the complete exercise of the Pre-Funded Warrant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .